Our mission is to find, develop, and commercialize medicines that enhance the quality of life for humans, animals, and agriculture crops. We aim to achieve this by harnessing the potential of valuable cytoskeletal drug targets and cutting-edge small-molecule drug discovery technologies.

At Kainomyx, we have brought together a team that thrives on innovation. This team combines leading cytoskeletal biology scientists with experienced drug hunters. Our founders have made groundbreaking discoveries that reveal how cytoskeletal proteins work and how they influence movement in biology.

With our cytoskeleton platform technology, we are actively addressing several unmet needs. Our relentless efforts in small molecule drug discovery have led to significant progress and the development of a pipeline of innovative programs.